These cells can differentiate into virtually any tissue type, enabling therapies that address genetic diseases, tissue damage, and other chronic conditions. However, a critical bottleneck remains: immune rejection. The solution? iPSC haplobanks—curated repositories of clinical-grade iPSC lines from donors with homozygous human leukocyte antigen (HLA) haplotypes. These banks aim to maximize compatibility and reduce the […]